Evidence 1
Activity
Activity
12% Hemolysis
Toxicity
80 µg/mL
Hemolytic
Cytotoxic
12% Hemolysis | 80 | µg/mL | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions | Biochim Biophys Acta | 2006